U.S. trade negotiator discusses COVID-19 IP waiver with Moderna CEO

  • 📰 Reuters
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Property Property Headlines News

Property Property Latest News,Property Property Headlines

U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna (MRNA.O) to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai's office said.

Moderna coronavirus disease vaccines are pictured at a rural vaccination site in Columbus, New Mexico, U.S., April 16, 2021. REUTERS/Paul Ratje

U.S. Trade Representative Katherine Tai on Wednesday met virtually with the top executive of drugmaker Moderna to discuss a proposed waiver of certain intellectual property rights in response to the COVID-19 pandemic, Tai's office said. Tai and Moderna Chief Executive Stephane Bancel also discussed increasing vaccine production and global health issues, Tai's office said in a statement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

▬003 Respectfully, no ones stopping people from injecting vaccines on themselves just don't make it mandatory to healthy people/infants like its a passport. Is there a study that proves vaccines are more effective/safer than the cheaper medicine HCQ+Z(proven safe by NIH) ▬003

But I thought Moderna already waived their patent rights?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in PROPERTY

Property Property Latest News, Property Property Headlines